Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine during awake craniotomy and postoperative inflammatory/stress response
PACTR202408593043200Not yet recruiting
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexmedetomidine in Chronic subdural haematoma (CSDH) (2 arms). Primary endpoints: C-reactive protein level, Interleukin-6 level and 1 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on PACTR202408593043200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408593043200.